Yoon, D. H., Cho, H., Hyung, J., Choi, Y. S., Jeon, Y., Kim, S. J., Koh, Y., Yun, N., Lee, W., Kim, C., Jang, M. H. (2025). Trial in progress: A Phase 2a Study of GI-102 (CD80/IL2v3) as a consolidation therapy in patients with relapsed/refractory diffuse large B-cell lymphoma following anti-CD19 chimeric antigen receptor T-cell therapy (CARNATION trial). Blood. https://doi.org/10.1182/blood-2025-2399